title,publisher,link,providerPublishTime
Decoding Johnson & Johnson (JNJ): A Strategic SWOT Insight,GuruFocus.com,https://finance.yahoo.com/news/decoding-johnson-johnson-jnj-strategic-050203028.html,2024-10-24 05:02:03
J&Jâ€™s Darzalex combination gains expanded label for multiple myeloma in Europe,Pharmaceutical Technology,https://finance.yahoo.com/m/f2e07455-5933-39f7-9b02-c4b6612231ac/j%26j%E2%80%99s-darzalex-combination.html,2024-10-23 21:03:43
Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know,Zacks,https://finance.yahoo.com/news/investors-heavily-search-johnson-johnson-130018606.html,2024-10-23 13:00:18
Johnson & Johnson's Janssen-Cilag Says EU Approves Indication Extension for Multiple Myeloma Treatment,MT Newswires,https://finance.yahoo.com/news/johnson-johnson-apos-janssen-cilag-110417166.html,2024-10-23 11:04:17
This Setback for Johnson & Johnson Is 1 More Green Light for Eli Lilly's Stock,Motley Fool,https://finance.yahoo.com/m/f2fda475-bfab-3495-b4b4-328cdc410c58/this-setback-for-johnson-%26.html,2024-10-23 08:30:00
5 Large Drug Stocks Likely to Outpace Q3 Earnings Estimates,Zacks,https://finance.yahoo.com/news/5-large-drug-stocks-likely-123100328.html,2024-10-22 12:31:00
Johnson & Johnson's (NYSE:JNJ) investors will be pleased with their favorable 45% return over the last five years,Simply Wall St.,https://finance.yahoo.com/news/johnson-johnsons-nyse-jnj-investors-120027004.html,2024-10-22 12:00:27
"Daiwa Securities Adjusts Price Target on Johnson & Johnson to $170 From $150, Maintains Neutral Rating",MT Newswires,https://finance.yahoo.com/news/daiwa-securities-adjusts-price-target-095238860.html,2024-10-22 09:52:38
